What Current Research Shows Us
The current research suggests the COVID shots altered the innate immune system, which is likely to alter the adaptive immune system.
Within the body, we have the innate immune cells that are quick-acting, inflammatory, and target all foreign molecules the same way.
Some of these innate immune cells will eventually activate adaptive immune cells, called the T and B cells. These cells begin to work a few days after infection and require activation from innate immune cells to function properly. These T and B cells target infections and cancers through specific and varied pathways. They create an immune memory afterwards so that the immune system will be able to act faster the next time.
Innate Immune System Alterations: Interferons
Interferons (IFN) are antiviral proteins. There are three major types: type I, II, and III, categorized based on the receptors each IFN binds to.
One of the most important IFN is type 1 IFN; it acts globally, targeting many tissues and organs to protect from infections, autoimmune diseases, as well as cancers.
Studies show that they are particularly important in the early response to infection and cancer.
“Impaired type I IFN signaling is linked to many disease risks, most notably cancer, as type 1 IFN signaling suppresses proliferation of both viruses and cancer cells by arresting the cell cycle,” the authors, led by Dr. Stephanie Seneff from the Massachusetts Institute of Technology wrote.
IFN-alpha and IFN-beta are type 1 IFNs; these molecules alert other cells of a virus or cancer, and also stop infected and cancerous cells from proliferating, causing diseased cells to die.
However, research on spike protein and mRNA vaccines suggests that IFN-alpha action may be impaired when exposed to spike protein.
A study that exposed human cells to spike protein DNA to induce the cell to produce spike protein found that the cell shipped out the spike protein with two forms of microRNAs (miRNAs) that inhibited molecules that activated IFN-alpha/beta.
miRNA are short strands of RNA molecules that bind to the DNA in cells and can therefore regulate cell activity. These two miRNA inhibited an essential protein that activates the IFN-alpha/beta pathway. This implies that vaccinated individuals will have a reduced IFN-alpha/beta response and poorer immune clearance.
Seneff said that the reduced symptoms in the vaccinated are likely because of this reduced pathway, since the initial symptoms of COVID-19 are caused by actions of the interferon action. This is why many vaccinated individuals are getting infected with rebound symptoms.
“[The vaccinated] don’t get the symptoms…don’t feel as sick, but actually, you’re spreading the disease like crazy because you’re not fighting it off.”
This also means that the virus will stick around in vaccinated individuals for longer, and if the disease is not cleared after a long period of time, it can cause severe disease down the line.
This hypothesis also concordant with hospitalization and mortality rates in New South Wales, an Australian state where over 95 percent of the population has been fully vaccinated, with many people receiving one or two boosters.
Hospitalitization rates and mortality rates are significantly higher in the boosted and fully vaccinated cohort, with lower rates in the unvaccinated and patients that have only received one dose.
Reduced T Cell Response
T cells and B cells are adaptive immune cells, meaning that they engage in specific and targeted attacks rather than attacking all foreign invaders the same way, which is what innate immune cells do.
Both cell types are very powerful, but both need to be activated first through innate immune system pathways to develop strong, specified attacks.
Killer T cells engage in close combat with diseased and cancerous cells by punching holes into them whereas B plasma cells work long-range, releasing antibodies into fluids in the body to surround and neutralize toxins, bacteria, and viruses. B cells also play a role in cancer, though their function and importance are not well understood.
T cells have been extensively studied for the important role they play in cancer by killing cancer cells directly. The activity of T cells have often been used to predict disease outcomes in cancer patients.
However, recent studies have shown that innate immune function has been altered in those injected with the COVID shots. A preprint study found receptors that activate T cell action, including TLR7/8 (toll like receptors 7 and 8), are reduced in vaccinated individuals.
Further, a Chinese study of people who have been vaccinated with the spike protein-inducing COVID-19 shots found that gene activity for what proteins and pathways are turned on and off have changed across most immune cells.
This raises questions about our traditional understanding of the innate immune cell to T cell activation pathway and whether vaccinated individuals will have an immune system that responds similarly to how it was before vaccination.
The study found T cell activity was reduced as well as an increased inflammatory response in the immediate weeks following vaccination, which, in the long-term, puts people at risk for cancer.
“These data suggested that after vaccination, at least by day 28, other than generation of neutralizing antibodies, people’s immune systems, including those of lymphocytes (T cells, B cells, natural killer cells) and monocytes (innate immune cells), were perhaps in a more vulnerable state,” the authors wrote.
These findings overlap with pathologist Dr. Ryan Cole’s observations at his medical laboratory, Cole Diagnostics.
Cole told Jan Jekielek on American Thought Leaders that after vaccinations started rolling out in the older population, he noticed the reappearance of Molluscum contagiosum, a parapoxvirus that most people get in childhood and is kept in check by the immune system from the teenage years onward.
Though the uptick is unusual, as Cole saw more cases he grew concerned that the vaccines may be driving a form of “immune dysregulation,” meaning a possible breakdown to established immune controls. Since these viruses are normally kept in check by T cells, which also keep cancers in check, a loss of immune memory against viruses could be a sign of loss of control in cancers.
“About a month or two later, all of a sudden there are certain types of cancers that I commonly see in the laboratory, after 500,000 patients…I started seeing endometrial cancers go up and there’s certain type… Melanomas, I started seeing thicker and earlier as well.”
Since then he has shared his findings in other lectures and found that other doctors and nurses around the world have made similar observations of increased rates of cancer cases.
An analysis by The Expose on VAERS data also indicated an uptick of cancer after COVID-19 vaccines by 143,233 percent.
Developing Cancer After Vaccination
In addition to cancers relapsing, there are also cases of sudden cancer development in previously cancer-free people after vaccination.
By Marina Zhang
“We’re seeing an alteration of the innate immune response,” says pathologist Dr. Ryan Cole, founder of Cole Diagnostics.
In recent months, Cole said he started seeing a number of disturbing trends under the microscope: the appearance of a childhood disease in adults and an uptick in rare cancers. Other doctors have echoed his observations, he says, but rigorous studies are not being conducted.
“You cannot find that for which you do not look,” he says.
We also take a look at what factors impact how an individual fares with COVID-19. America has a vitamin D crisis, which is essential to a functioning immune system, Cole says. “This is a public health message that is so critical, because so goes your vitamin D level, so goes your overall ability to fight off not just COVID, but any virus in any viral season.”